FDA orders Johnson & Johnson to throw out 60 million Covid vaccine doses worth $ 600 MILLION at troubled Baltimore plant that had several violations in major blow to countries facing shortages of shots The FDA has ordered 60 million doses of Johnson & Johnson’s coronavirus vaccine to be discarded on Friday The shots were… Read More: FDA ordered Johnson & Johnson to throw out 60 million… »
Johnson & Johnson’s single-shot COVID-19 vaccine will begin shipping in the U.S. on Monday morning, marking the third shot in the country’s arsenal after a greenlight from the FDA and a panel with the Centers for Disease Control and Prevention (CDC). McKesson, the government-selected distribution partner for the vaccination effort, announced Monday it started distribution… Read More: Johnson & Johnson COVID-19 vaccine begins shipping, third jab in… »
WASHINGTON – An analysis by U.S. regulators say Johnson & Johnson’s single-dose vaccine protects against COVID-19. The report Wednesday confirmed the vaccine is about 66% effective overall at preventing moderate to severe COVID-19. On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend… Read More: The Latest: Johnson & Johnson single shot awaits approval »
Johnson & Johnson on Tuesday reported third-quarter earnings and revenue that beat expectations, boosted by higher sales of cancer and other prescription drugs, despite multimillion-dollar legal problems from talc and opioids. Here’s what the company reported compared with Wall Street estimates, based on a survey of analysts by Refinitiv: Adjusted earnings per share: $ 2.12… Read More: Johnson & Johnson earnings beat expectations despite legal challenges from… »